Revised International Prognostic Scoring System for Myelodysplastic Syndromes

  • Slides: 8
Download presentation
Revised International Prognostic Scoring System for Myelodysplastic Syndromes by Peter L. Greenberg, Heinz Tuechler,

Revised International Prognostic Scoring System for Myelodysplastic Syndromes by Peter L. Greenberg, Heinz Tuechler, Julie Schanz, Guillermo Sanz, Guillermo Garcia-Manero, Francesc Solé, John M. Bennett, David Bowen, Pierre Fenaux, Francois Dreyfus, Hagop Kantarjian, Andrea Kuendgen, Alessandro Levis, Luca Malcovati, Mario Cazzola, Jaroslav Cermak, Christa Fonatsch, Michelle M. Le Beau, Marilyn L. Slovak, Otto Krieger, Michael Luebbert, Jaroslaw Maciejewski, Silvia M. M. Magalhaes, Yasushi Miyazaki, Michael Pfeilstöcker, Mikkael Sekeres, Wolfgang R. Sperr, Reinhard Stauder, Sudhir Tauro, Peter Valent, Teresa Vallespi, Arjan A. van de Loosdrecht, Ulrich Germing, and Detlef Haase Blood Volume 120(12): 2454 -2465 September 20, 2012 © 2012 by American Society of Hematology

IWG-PM patients marrow blast subgroups. Peter L. Greenberg et al. Blood 2012; 120: 2454

IWG-PM patients marrow blast subgroups. Peter L. Greenberg et al. Blood 2012; 120: 2454 -2465 © 2012 by American Society of Hematology

IWG-PM patients marrow blast subgroups: Impact on AML evolution. Peter L. Greenberg et al.

IWG-PM patients marrow blast subgroups: Impact on AML evolution. Peter L. Greenberg et al. Blood 2012; 120: 2454 -2465 © 2012 by American Society of Hematology

Survival based on IPSS-R prognostic risk-based categories. Peter L. Greenberg et al. Blood 2012;

Survival based on IPSS-R prognostic risk-based categories. Peter L. Greenberg et al. Blood 2012; 120: 2454 -2465 © 2012 by American Society of Hematology

AML evolution based on IPSS-R prognostic risk-based categories. Peter L. Greenberg et al. Blood

AML evolution based on IPSS-R prognostic risk-based categories. Peter L. Greenberg et al. Blood 2012; 120: 2454 -2465 © 2012 by American Society of Hematology

Survival based on patient ages > 60 years vs ≤ 60 years related to

Survival based on patient ages > 60 years vs ≤ 60 years related to their IPSS-R prognostic riskbased categories (Kaplan-Meier curves). Peter L. Greenberg et al. Blood 2012; 120: 2454 -2465 © 2012 by American Society of Hematology

Age-adjusted IPSS-R risk categories. Peter L. Greenberg et al. Blood 2012; 120: 2454 -2465

Age-adjusted IPSS-R risk categories. Peter L. Greenberg et al. Blood 2012; 120: 2454 -2465 © 2012 by American Society of Hematology

Comparison of IPSS-R and IPSS subgroups within the IWG-PM database patient cohort. Peter L.

Comparison of IPSS-R and IPSS subgroups within the IWG-PM database patient cohort. Peter L. Greenberg et al. Blood 2012; 120: 2454 -2465 © 2012 by American Society of Hematology